Trial · NCT04094584
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Participants Retained in Study at 3 Months | 3 months | Percentage of enrolled participants who attend final study visit at the end of the intervention period |
| Primary | Retention at 12 Months | 12 months | Percentage of enrolled participants who complete final study visit at the end of the follow up periods |
| Primary | Change in Daily Total Alcohol Consumption From Baseline at 3 Months | 3 months after enrollment | Self-reported total daily alcohol consumption at 3 months, compared to baseline |
| Primary | Change in Total Alcohol Consumption at 12 Months | 12 months after enrollment | Change in self-reported total daily alcohol consumption from baseline |
| Secondary | Change in Quality of Life Score at 3 Months | 3 months after enrollment | Kemp Quality of Life score at 3 months compared to baseline. Score is 1-7 with higher scores indicating higher quality of life. |
| Other | Substance Use Treatment Utilization | 12 months | percentage of participants self-reporting engagement in community substance use treatment programs |
| Other | Recruitment | 12 months | Percentage of those approached who enroll in the study |
| Other | Continued Naltrexone Use After Intervention Period | 3 months | Percentage of enrolled who self reported continuing treatment with naltrexone through their primary physician after the end of the study intervention period |
| Other | Change in ED Utilization | 12 months before and after enrollment | Change in the number of emergency department visits determined by electronic medical record review |
| Other | Change in WHO Drinking Risk Level | 3 months after enrollment | Change in World Health Organization drinking risk level from baseline. Risk levels are scored 1-4 with higher scores indicating more severe health risk from alcohol use |
| Other | Change in Alcohol Related Life Consequences (Short Inventory of Problems Scale, Version 2R: SIP-2R) | 3 months after enrollment | Change in life consequences due to alcohol use from baseline as measured by revised short inventory of problems (score 0-45 with higher scores indicating more severe alcohol related life consequences) |
| Other | Receipt of All Study Naltrexone Injections | 3 months | Percentage of participants receiving all 3 scheduled naltrexone injections received |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04094584/registered